Novartis Stockpiles: Pharma Braces for Potential US Tariffs
Update: 2025-09-20
Description
Is your medicine cabinet safe from Trump's tariffs? Novartis CEO reveals the company's secret plan to stockpile drugs in the U.S. until 2026, bracing for a potential 250% tariff hike. Find out how this pharma giant is spending billions to shift manufacturing to America, and what it means for the future of drug prices and availability. Don't miss this insider look at the high-stakes game being played between Big Pharma and Washington.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
